Haleon was among the FTSE 100 index top performers after it said that pretax profit for 2023 slightly rose supported by better-than-expected sales, with positive volume, price and organic growth ...

Pfizer PFE-1.21%decrease; red down pointing triangle is raising around $3.5 billion from the sale of part of its stake in consumer-healthcare business Haleon HLN-0.97%decrease; red down pointing ...

Haleon generated £1.9bn in free cash flow, up £369m year-on-year. It reduced net debt to £7.9bn. The company’s leverage ratio ...

GSK spun off Haleon to form a new consumer healthcare entity, driven by activist investor pressure and its underperforming share price. Haleon’s financials show steady growth with 2023 revenues ...

Haleon, a global consumer health company, is investing $54.2 million to upgrade its research & development (R&D) facility in Richmond, Virginia. The modernization will enable the company to expand ...

Haleon sells health products internationally with stable operations and modest growth through a good performance in oral health products, and growth in Asia Pacific. The company's financials have ...

Pfizer (NYSE:PFE) announced Tuesday it plans to sell roughly 700M ordinary shares in Haleon (NYSE:HLN) to lower its stake in ...

LONDON (Reuters) -Haleon believes it is not liable for any claims that may arise from U.S. litigation over the heartburn drug Zantac, the London-listed company's CEO Brian McNamara told Reuters on ...

“It’s crazy to say that, isn’t it?” A new collaboration between Microsoft and global consumer health company Haleon aims to make health product information more accessible for people who are blind or ...

RICHMOND, Va. — Haleon, a global company behind home healthcare products like Advil, Tums and Aquafresh, announced Monday its plan to upgrade its Richmond research and development facility.

Haleon PLC HLN shares advanced 2.46% to £3.75 Friday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.64% to 7,964.18 ...

Haleon PLC HLN shares slid 1.91% to £3.86 Monday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index UKX falling 0.10% to 8,638.01. Haleon PLC ...